Antiarrhythmic drugs.
D000200:Action Potentials / Q000187:drug effects; D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D001145:Arrhythmias, Cardiac / Q000188:drug therapy*; D001949:Bretylium Compounds / Q000627:therapeutic use; D002462:Cell Membrane / Q000187:drug effects; D006329:Heart Conduction System / Q000187:drug effects*; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D008012:Lidocaine / Q000627:therapeutic use; D008564:Membrane Potentials / Q000187:drug effects; D010646:Phentolamine / Q000627:therapeutic use; D010672:Phenytoin / Q000627:therapeutic use; D011342:Procainamide / Q000627:therapeutic use; D011804:Quinolines / Q000627:therapeutic use
D000889:Anti-Arrhythmia Agents; D001949:Bretylium Compounds; D011804:Quinolines; D010672:Phenytoin; D008012:Lidocaine; D011342:Procainamide; D010646:Phentolamine